Keros Therapeutics Inc (KROS)

19.42 +0.59 (+3.13%) USD  |  NASDAQ  |  Dec 16, 16:00
18.99 -0.43 (-2.21%) After-Hours: 20:00
More

Keros Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Aptevo Therapeutics Inc Upgrade
Corcept Therapeutics Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Scholar Rock Holding Corp Upgrade
Trevi Therapeutics Inc --

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade